The first knock-in rat model for glutaric aciduria type I allows further insights into pathophysiology in brain and periphery.


Journal

Molecular genetics and metabolism
ISSN: 1096-7206
Titre abrégé: Mol Genet Metab
Pays: United States
ID NLM: 9805456

Informations de publication

Date de publication:
06 2021
Historique:
received: 04 02 2021
revised: 10 03 2021
accepted: 30 03 2021
pubmed: 10 5 2021
medline: 11 9 2021
entrez: 9 5 2021
Statut: ppublish

Résumé

Glutaric aciduria type I (GA-I, OMIM # 231670) is an inborn error of metabolism caused by a deficiency of glutaryl-CoA dehydrogenase (GCDH). Patients develop acute encephalopathic crises (AEC) with striatal injury most often triggered by catabolic stress. The pathophysiology of GA-I, particularly in brain, is still not fully understood. We generated the first knock-in rat model for GA-I by introduction of the mutation p.R411W, the rat sequence homologue of the most common Caucasian mutation p.R402W, into the Gcdh gene of Sprague Dawley rats by CRISPR/CAS9 technology. Homozygous Gcdh

Identifiants

pubmed: 33965309
pii: S1096-7192(21)00084-6
doi: 10.1016/j.ymgme.2021.03.017
pii:
doi:

Substances chimiques

Arginine 94ZLA3W45F
Glutaryl-CoA Dehydrogenase EC 1.3.8.6
Lysine K3Z4F929H6
Creatine MU72812GK0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

157-181

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Mary Gonzalez Melo (M)

Pediatric Metabolic Unit, Pediatrics, Woman-Mother-Child Department, University of Lausanne and University Hospital of Lausanne, Switzerland. Electronic address: mary.gonzalez-melo@chuv.chm.

Noémie Remacle (N)

Pediatric Metabolic Unit, Pediatrics, Woman-Mother-Child Department, University of Lausanne and University Hospital of Lausanne, Switzerland.

Hong-Phuc Cudré-Cung (HP)

Pediatric Metabolic Unit, Pediatrics, Woman-Mother-Child Department, University of Lausanne and University Hospital of Lausanne, Switzerland.

Clothilde Roux (C)

Service of Clinical Chemistry, University of Lausanne and University Hospital of Lausanne, Switzerland. Electronic address: Clothilde.Roux@chuv.ch.

Martin Poms (M)

Klinische Chemie und Biochemie Universitäts-Kinderspital Zürich, Switzerland. Electronic address: Martin.Poms@kispi.uzh.ch.

Cristina Cudalbu (C)

CIBM Center for Biomedical Imaging, Switzerland; Animal Imaging and Technology, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland. Electronic address: cristina.cudalbu@epfl.ch.

Madalena Barroso (M)

University Children's Research, UCR@Kinder-UKE, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: m.barroso@uke.de.

Søren Waldemar Gersting (SW)

University Children's Research, UCR@Kinder-UKE, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: gersting@uke.de.

René Günther Feichtinger (RG)

Department of Pediatrics, University Hospital Salzburg, Paracelsus Medical University, Salzburg, Austria. Electronic address: r.feichtinger@salk.at.

Johannes Adalbert Mayr (JA)

Department of Pediatrics, University Hospital Salzburg, Paracelsus Medical University, Salzburg, Austria. Electronic address: h.Mayr@salk.at.

Michele Costanzo (M)

Department of Molecular Medicine and Medical Biotechnology, School of Medicine, University of Naples Federico II, 80131 Naples, Italy; CEINGE - Biotecnologie Avanzate s.c.ar.l., 80145 Naples, Italy. Electronic address: michele.costanzo@unina.it.

Marianna Caterino (M)

Department of Molecular Medicine and Medical Biotechnology, School of Medicine, University of Naples Federico II, 80131 Naples, Italy; CEINGE - Biotecnologie Avanzate s.c.ar.l., 80145 Naples, Italy. Electronic address: marianna.caterino@unina.it.

Margherita Ruoppolo (M)

Department of Molecular Medicine and Medical Biotechnology, School of Medicine, University of Naples Federico II, 80131 Naples, Italy; CEINGE - Biotecnologie Avanzate s.c.ar.l., 80145 Naples, Italy. Electronic address: margherita.ruoppolo@unina.it.

Véronique Rüfenacht (V)

Division of Metabolism and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland. Electronic address: veronique.ruefenacht@kispi.uzh.ch.

Johannes Häberle (J)

Division of Metabolism and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland. Electronic address: Johannes.Haeberle@kispi.uzh.ch.

Olivier Braissant (O)

Service of Clinical Chemistry, University of Lausanne and University Hospital of Lausanne, Switzerland. Electronic address: Olivier.Braissant@chuv.ch.

Diana Ballhausen (D)

Pediatric Metabolic Unit, Pediatrics, Woman-Mother-Child Department, University of Lausanne and University Hospital of Lausanne, Switzerland. Electronic address: diana.ballhausen@chuv.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH